Alport Connect 2026, the annual Alport syndrome patient and family meeting in US
18-19 July 2026
Philadelphia
ENYO Pharma is sponsoring and will attend Alport Connect 2026 organized by the American Alport Syndrome Foundation (ASF), the Alport syndrome patient-led non-profit organization in the US.
ENYO Pharma will meet patients and their families to present the results of the Phase 2 “ALPESTRIA-1” clinical study with Vonafexor in Alport syndrome patients.
https://alportsyndrome.org/events/alport-connect-2026/
Latest Press Release 